All‐cause mortality · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
1 finding from 1 review
no estimate extracted
4 participants
GRADE not reported
Number of platelet transfusions per participant up to 30 days from study entry · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
1 finding from 1 review
Thromboembolic events · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
1 finding from 1 review
Quality of life ‐ not reported · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of participants with at least 1 bleeding episode · people with haematological disorders undergoing intensive chemotherapy or stem cell transplantation
It is very uncertain whether the intervention changes number of participants with at least 1 bleeding episode (very low certainty).
1 finding from 1 review
Intervention not reported
Change in Exercise Capacity (6MWD) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
1 finding from 1 review
Intervention not reported
Mortality · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
The intervention showed no clear difference in mortality (low certainty).
1 finding from 1 review
Intervention not reported
Improvement in WHO Functional Class · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
The intervention showed no clear difference in improvement in WHO Functional Class (low certainty).
1 finding from 1 review
Intervention not reported
Serious Adverse Events (Participants with one or more event) · Adults (>18 years) with pulmonary hypertension of varied aetiology (PAH, CTEPH and left heart disease)
It is very uncertain whether the intervention changes serious Adverse Events (Participants with one or more event) (very low certainty).
1 finding from 1 review
Pain‐free at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
High
Pain‐free at 1 hour · adults with episodic tension‐type headache
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Pain‐free or mild pain at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Any adverse event · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Serious adverse events · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Pain‐free at 1 hour · adults with episodic tension‐type headache
2 findings from 1 review
no estimate extracted
Studies not reported
Moderate
no estimate extracted
Studies not reported
Moderate
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Pain‐free or mild pain at 2 hours · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
High
Any adverse event · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
High
Serious adverse events · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate